Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-25-014570
Filing Date
2025-04-18
Accepted
2025-04-18 16:15:28
Documents
22
Period of Report
2025-06-11

Document Format Files

Seq Description Document Type Size
1 PRE 14A ny20044950x1_pre14a.htm   iXBRL PRE 14A 1060620
6 logo_bionano02.jpg GRAPHIC 30849
7 ny20044950x1_pc01.jpg GRAPHIC 712594
8 ny20044950x1_pc02.jpg GRAPHIC 628798
9 ny20044950x1_pvp01x1.jpg GRAPHIC 112454
10 ny20044950x1_pvp02x1.jpg GRAPHIC 96607
  Complete submission text file 0001140361-25-014570.txt   6003989

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION - SCHEMA bngo-20250611.xsd EX-101.SCH 4179
3 INLINE XBRL TAXONOMY EXTENSION - DEFINITION LINKBASE bngo-20250611_def.xml EX-101.DEF 3299
4 INLINE XBRL TAXONOMY EXTENSION - LABEL LINKBASE bngo-20250611_lab.xml EX-101.LAB 14948
5 INLINE XBRL TAXONOMY EXTENSION - PRESENTATION LINKBASE bngo-20250611_pre.xml EX-101.PRE 8856
24 EXTRACTED XBRL INSTANCE DOCUMENT ny20044950x1_pre14a_htm.xml XML 202926
Mailing Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121 (858) 888-7600
Bionano Genomics, Inc. (Filer) CIK: 0001411690 (see all company filings)

EIN.: 261756290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38613 | Film No.: 25850572
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)